THE TRANSMEMBRANE FORM OF TUMOR-NECROSIS-FACTOR IS THE PRIME ACTIVATING LIGAND OF THE 80 KDA TUMOR-NECROSIS-FACTOR RECEPTOR

被引:1251
作者
GRELL, M
DOUNI, E
WAJANT, H
LOHDEN, M
CLAUSS, M
MAXEINER, B
GEORGOPOULOS, S
LESSLAUER, W
KOLLIAS, G
PFIZENMAIER, K
SCHEURICH, P
机构
[1] HELLEN INST PASTEUR,MOLEC GENET LAB,GR-11521 ATHENS,GREECE
[2] F HOFFMANN LA ROCHE & CO LTD,PHARMACEUT RES,CH-4002 BASEL,SWITZERLAND
[3] MAX PLANCK INST PHYSIOL & CLIN RES,WG KERCKHOFF INST,D-61231 BAD NAUHEIM,GERMANY
关键词
D O I
10.1016/0092-8674(95)90192-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The 60 kDa tumor necrosis factor receptor (TNFR(60)) is regarded as the major signal transducer of TNF-induced cellular responses, whereas the signal capacity and role of the 80 kDa TNFR (TNFR(80)) remain largely undefined, We show here that the transmembrane form of TNF is superior to soluble TNF in activating TNFR(80) in various systems such as T cell activation, thymocyte proliferation, and granulocyte/macrophage colony-stimulating factor production, Intriguingly, activation of TNFR(80) by membrane TNF can lead to qualitatively different TNF responses such as rendering resistant tumor cells sensitive to TNF-mediated cytotoxicity. This study demonstrates that the diversity of TNF effects can be controlled through the differential sensitivity of TNFR(80) for the two forms of TNF and suggests an important physiological role for TNFR(80) in local inflammatory responses.
引用
收藏
页码:793 / 802
页数:10
相关论文
共 43 条
[1]
ADOLF RA, 1994, EPIDERMAL GROWTH FAC, P63
[2]
IDENTIFICATION OF A SOURCE OF BIOLOGICALLY-ACTIVE CD40 LIGAND [J].
ARMITAGE, RJ ;
SATO, TA ;
MACDUFF, BM ;
CLIFFORD, KN ;
ALPERT, AR ;
SMITH, CA ;
FANSLOW, WC .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (08) :2071-2076
[3]
THE 26-KD TRANSMEMBRANE FORM OF TUMOR-NECROSIS-FACTOR-ALPHA ON ACTIVATED CD4+ T-CELL CLONES PROVIDES A COSTIMULATORY SIGNAL FOR HUMAN B-CELL ACTIVATION [J].
AVERSA, G ;
PUNNONEN, J ;
DEVRIES, JE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (06) :1575-1585
[4]
DUAL ROLE OF THE P75 TUMOR-NECROSIS-FACTOR (TNF) RECEPTOR IN TNF CYTOTOXICITY [J].
BIGDA, J ;
BELETSKY, I ;
BRAKEBUSCH, C ;
VARFOLOMEEV, Y ;
ENGELMANN, H ;
BIGDA, J ;
HOLTMANN, H ;
WALLACH, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (02) :445-460
[5]
SOLUBLE TNF AND MEMBRANE TNF EXPRESSED ON CD4+T LYMPHOCYTES DIFFER IN THEIR ABILITY TO ACTIVATE MACROPHAGE ANTILEISHMANIAL DEFENSE [J].
BIRKLAND, TP ;
SYPEK, JP ;
WYLER, DJ .
JOURNAL OF LEUKOCYTE BIOLOGY, 1992, 51 (03) :296-299
[6]
IDENTIFICATION OF 2 TYPES OF TUMOR-NECROSIS-FACTOR RECEPTORS ON HUMAN CELL-LINES BY MONOCLONAL-ANTIBODIES [J].
BROCKHAUS, M ;
SCHOENFELD, HJ ;
SCHLAEGER, EJ ;
HUNZIKER, W ;
LESSLAUER, W ;
LOETSCHER, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (08) :3127-3131
[7]
VASCULAR-PERMEABILITY FACTOR - A TUMOR-DERIVED POLYPEPTIDE THAT INDUCES ENDOTHELIAL-CELL AND MONOCYTE PROCOAGULANT ACTIVITY, AND PROMOTES MONOCYTE MIGRATION [J].
CLAUSS, M ;
GERLACH, M ;
GERLACH, H ;
BRETT, J ;
WANG, F ;
FAMILLETTI, PC ;
PAN, YCE ;
OLANDER, JV ;
CONNOLLY, DT ;
STERN, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (06) :1535-1545
[8]
DETECTION AND CHARACTERIZATION OF HIGH-AFFINITY PLASMA-MEMBRANE RECEPTORS FOR HUMAN INTERLEUKIN-1 [J].
DOWER, SK ;
KRONHEIM, SR ;
MARCH, CJ ;
CONLON, PJ ;
HOPP, TP ;
GILLIS, S ;
URDAL, DL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (02) :501-515
[9]
ENGELMANN H, 1990, J BIOL CHEM, V265, P14497
[10]
DECREASED SENSITIVITY TO TUMOR-NECROSIS-FACTOR BUT NORMAL T-CELL DEVELOPMENT IN TNF RECEPTOR-2-DEFICIENT MICE [J].
ERICKSON, SL ;
DESAUVAGE, FJ ;
KIKLY, K ;
CARVERMOORE, K ;
PITTSMEEK, S ;
GILLETT, N ;
SHEEHAN, KCF ;
SCHREIBER, RD ;
GOEDDEL, DV ;
MOORE, MW .
NATURE, 1994, 372 (6506) :560-563